Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Trade Show

Click Therapeutics to Participate in the BTIG Digital Health Forum


Click Therapeutics, Inc. ("Click"), a leader in Digital Therapeuticstm as prescription medical treatments, today announced that David Benshoof Klein, Co-Founder and CEO, and Randall Stanicky, Chief Financial Officer, will take part in the virtual BTIG Digital Health Forum on Monday, November 15, 2021. As part of the event, Mr. Klein will participate in a digital therapeutics panel discussion: "Setting the Pace: Commercializing Prescription Digital Therapeutics (PDTs) and Expanding the Pipeline" at 2 p.m. ET.

About Click Therapeutics

Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for patients with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click's Digital Therapeuticstm enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click's industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click's lead prescription program has recently entered a pivotal, fully remote, randomized, controlled trial on the Verily platform for the treatment of Major Depressive Disorder in up to 540 adults. For more information on Click, visit ClickTherapeutics.com.


These press releases may also interest you

at 19:13
LG Energy Solution to Take Firm Stance Against Patent Infringers
A surge in patent infringement by latecomers in the battery industry, and subsequent market distortion caused by unlicensed use of patented technology, calls for strong countermeasures to level the playing fieldLG Energy Solution believes that at...

at 19:05
Xaira Therapeutics Launches to Deliver Transformative Medicines by Advancing and Harnessing AI for Drug Discovery and Development
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...

at 19:00
Visionary Holdings Inc. Announcement of Management Change
Visionary Holdings Inc. (the "Company") , a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries in Canada and market partners in China, today announced on April 22, 2024, the...

at 19:00
Kansas Proving Grounds Partners with SkyScoutAI Innovations Inc. to Deploy AI-Powered Drones for Wildfire Solution at America's First Carbon Neutral Industrial Park
The Kansas Proving Grounds at Great Plains Industrial Park, a leading facility for testing and innovation, is proud to announce its partnership with SkyscoutAI Innovations Inc., a pioneer in AI-powered wildfire detection and response using drones and...

at 19:00
UST Strengthens Presence in the Australian Market with Strategic Acquisition of Leading Consulting Firm Strativity Group
UST, a leading digital transformation solutions company, today announced that it has acquired Strativity Group, a boutique strategy consultancy specialising in customer-centric transformations. Strativity is renowned for delivering customer...

at 18:45
IANS Research Receives Strategic Investment From the Apax Digital Funds to Accelerate Growth and Market Leadership in Information Security
IANS Research, the leading provider of independent research and advisory services for the information security industry, has announced a new strategic investment from the Apax Digital Fund II (the "Apax Digital Funds"). IANS is a widely recognized...

More news about Science and technology...


News published on and distributed by: